Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2008
Reporting Period: Third Quarter of 2008
This filing serves as a notification that the Company issued a press release announcing its financial results for the third quarter of 2008. The actual financial data is contained in the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2), which are incorporated by reference but not reproduced in the text of this 8-K.
Key Financial Metrics
The text of this Form 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the referenced press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2).
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It only confirms the issuance of results for the third quarter of 2008.
Guidance, Outlook, and Risks
This document does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. Such information is expected to be found in the incorporated press release and supplemental exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 23, 2008) for specific Q3 2008 revenue and earnings figures.
- Access Exhibit 99.2 (Supplemental information on www.bms.com) for detailed financial breakdowns not included in the press release.
- Compare Q3 2008 results against Q3 2007 figures provided in the press release to assess year-over-year performance.
- Verify any forward-looking statements or guidance updates included in the press release.